Used primarily in pharmaceutical research as a key intermediate in the synthesis of serotonin receptor modulators. It shows particular relevance in developing compounds targeting central nervous system disorders, including depression, anxiety, and schizophrenia. Its structure allows selective interaction with 5-HT2A and 5-HT2C receptors, making it valuable in designing potent and selective therapeutic agents. Additionally, it has been explored in the development of radiolabeled derivatives for use in positron emission tomography (PET) imaging to study receptor distribution and occupancy in the brain.